Analystreport

Pacira BioSciences (NASDAQ:PCRX) had its "sell (d+)" rating reaffirmed by analysts at Weiss Ratings.

Pacira BioSciences, Inc.  (PCRX) 
Last pacira biosciences, inc. earnings: 2/20 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.pacira.com